Stanford, CA, United States of America

Quynh-Thu Le

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Quynh-Thu Le: Innovator in Salivary Stem Cell Research

Introduction

Quynh-Thu Le is a notable inventor based in Stanford, California. He has made significant contributions to the field of stem cell research, particularly focusing on adult salivary stem cells. His innovative work aims to enhance the proliferation of these cells, which can have important implications for patients undergoing treatment for head and neck cancer.

Latest Patents

Quynh-Thu Le holds a patent titled "Compositions and methods for increasing proliferation of adult salivary stem cells." This patent outlines methods for increasing the proliferation of adult salivary stem cells by contacting them with an aldehyde dehydrogenase (ALDH) agonist. The methods described in the patent can be applied in vivo, in vitro, or ex vivo, providing a potential therapeutic approach for individuals undergoing radiotherapy for head and neck cancer.

Career Highlights

Quynh-Thu Le is affiliated with Leland Stanford Junior University, where he conducts his research. His work has garnered attention for its potential to improve the quality of life for cancer patients by enhancing the regeneration of salivary glands affected by treatment.

Collaborations

Quynh-Thu Le has collaborated with notable colleagues, including Che-Hong Chen and Daria D Mochly-Rosen. These collaborations have likely contributed to the advancement of his research and the development of innovative solutions in the field of stem cell therapy.

Conclusion

Quynh-Thu Le's contributions to salivary stem cell research highlight the importance of innovation in medical science. His patent and ongoing research efforts represent a significant step forward in providing therapeutic options for patients affected by head and neck cancer.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…